BIOAGE LABS, INC. Public Float
BIOAGE LABS, INC. (BIOA) had Public Float of $112.70 million as of 2025-06-30, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-24
- 2025-06-30: Entity Public Float $112.70M.
- 2024-09-26: Entity Public Float $473.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $112.70M 10-K · filed 2026-03-24 |
| 2024-09-26 | $473.50M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |